Error: Could not add to watchlist. X
+ Watchlist

CEL-SCI Corp

LSRM:GR
Stuttgart
1.55
EUR
0.01
0.72%
As of 10:30 AM EDT 6/26/2017
Open
1.57
Day Range
1.54 - 1.58
Volume
600
Previous Close
1.53
52Wk Range
0.03 - 11.70
1 Yr Return
-82.39%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
1.57
Day Range
1.54 - 1.58
Volume
600
Previous Close
1.53
52Wk Range
0.03 - 11.70
1 Yr Return
-82.39%
YTD Return
-43.82%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (m EUR)
14.203
Shares Outstanding (m)
9.193
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.16%
% Price Change
-0.03%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
CEL-SCI Corporation researches and develops certain drugs and vaccines. The Company's Multikine is being tested to determine if it is effective in improving the immune response of cancer patients. CEL-SCI is also developing other products. The Company is currently targeting diseases such as AIDS, herpes simplex, malaria, tuberculosis, prostate cancer, and breast cancer.
Address
8229 Boone Boulevard
Suite 802
Vienna, VA 22182
United States
Phone
1-703-506-9460
  • Geert R Kersten
    CEO/Treasurer
  • Eyal Talor
    Chief Scientific Officer
  • Patricia B Prichep
    Senior VP:Operations/Secy
  • Daniel H Zimmerman
    Senior VP:Research
  • John Cipriano
    Senior VP:Regulatory Affairs
Show More